Anouk van der Hoorn

Endovascular treatment versus no endovascular treatment after 6–24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial

Susanne G. H. Olthuis, F.A.V. Pirson, Florentina M.E. Pinckaers et al. · The Lancet · 2023 · 211 citations · Full text

Endovascular Technique, Cerebrovascular Disease, Thrombosis +17

Impact of sarcopenia on survival and late toxicity in head and neck cancer patients treated with radiotherapy

Maria I. van Rijn–Dekker, L. Van den Bosch, Johanna G.M. van den Hoek et al. · Radiotherapy and Oncology · 2020 · 128 citations · Full text

Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial

Wouter van der Steen, Rob A. van de Graaf, Vicky Chalos et al. · The Lancet · 2022 · 125 citations · Full text

Thrombosis, Cardiovascular Disease, Endovascular Stroke Treatment +14

CT‐measured skeletal muscle mass used to assess frailty in patients with head and neck cancer

Aniek T. Zwart, Anouk van der Hoorn, Peter M. A. van Ooijen et al. · Journal of Cachexia Sarcopenia and Muscle · 2019 · 105 citations · Full text

Clinical and Imaging Determinants of Collateral Status in Patients With Acute Ischemic Stroke in MR CLEAN Trial and Registry

Eveline Wiegers, Maxim J.H.L. Mulder, Ivo G.H. Jansen et al. · Stroke · 2020 · 70 citations · Full text